Donanemab [TRAILBLAZER]
On the day that this Randomised Controlled Trial was published in The Journal of the American Medical Association, 17 July 2023, headlines and news coverage TRAILBLAZED across the world [well … Continue reading Donanemab [TRAILBLAZER]